Interview Spotlights
Invaluable insight from leading experts
HIV not linked to COVID-19 risk, other highlights from AIDS 2020
W. David Hardy, MD, scientific and medical consultant, and adjunct professor of medicine in the division of infectious diseases at Johns Hopkins University School of Medicine, shared some important take-aways for clinicians from this year’s International AIDS Conference with Healio.
Shifting from daily to infrequent dosing will advance HIV treatment
Judith Feinberg, MD, from West Virginia University School of Medicine, spoke with Healio about important FDA approvals in HIV, the burden of drug resistance, threats to HIV control and the future of HIV treatment.
Reduce stigma, improve education to increase cancer treatment among patients with HIV
Infectious Disease News Chief Medical Editor Paul A. Volberding, MD, spoke with Healio about which types of cancer patients with HIV are more likely to develop, how HIV treatments have changed that risk, how cancer affects HIV treatment and how to increase cancer treatment among these patients.
Read more about